Teva Pharmaceuticals
TEVA
TEVA
458 hedge funds and large institutions have $4.98B invested in Teva Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 151 increasing their positions, 114 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.08% less ownership
Funds ownership: 53.83% → 50.75% (-3.1%)
14% less capital invested
Capital invested by funds: $5.76B → $4.98B (-$784M)
38% less call options, than puts
Call options by funds: $273M | Put options by funds: $441M
Holders
458
Holding in Top 10
9
Calls
$273M
Puts
$441M
Top Buyers
| 1 | +$125M | |
| 2 | +$119M | |
| 3 | +$83.1M | |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$73.2M |
| 5 |
Jane Street
New York
|
+$47.2M |
Top Sellers
| 1 | -$698M | |
| 2 | -$195M | |
| 3 | -$67.4M | |
| 4 |
Morgan Stanley
New York
|
-$24.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$23.6M |